Original ArticleIndian Journal of Pharmaceutical Education and ResearchVol. 54 | Issue 4 | 2020 | pp. 1072–1079Open access
Standardization of Trigonella foenum-graecum L. Seeds: A Quality by Design Approach
- 1,
- 1*,
- 2
- 1 Department of Pharmacognosy, KLE College of Pharmacy, Belagavi, KLE Academy of Higher Education and Research (KAHER) Belagavi, Karnataka, INDIA.
- 2 Department of Pharmaceutical Quality Assurance, KLE College of Pharmacy, Belagavi, KLE Academy of Higher Education and Research (KAHER) Belagavi, Karnataka, INDIA.
Published in Indian Journal of Pharmaceutical Education and Research
Correspondence: Kirankumar Hullatti
Department of Pharmacognosy, KLE College of Pharmacy, Belagavi, KLE Academy of Higher Education and Research (KAHER) Belagavi, Karnataka, INDIA.
Email: kkhullatti@gmail.com
Copyright: © 2020 Manuscript Technomedia. This is an open access article.
- Published:
- Jan 1, 2020
- Received:
- Mar 19, 2020
- Accepted:
- Oct 23, 2020
- DOI:
- 10.5530/ijper.54.4.202
How to cite
Gaonkar, V. P., Hullatti, K., & Mannur, V. (2020). Standardization of Trigonella foenum-graecum L. Seeds: A Quality by Design Approach. Indian Journal of Pharmaceutical Education and Research, 54(4), 1072–1079. https://doi.org/10.5530/ijper.54.4.202
Abstract
Aim: To standardize Trigonella foenum-graecum L. Seeds by developing QbD based HPLC method for identification and quantification of trigonelline in T. foenum graecum L. seeds, along with evaluation of various quality control parameters. Methods: The Analytical Target Profile and Critical Quality Attributes were determined followed by optimization of HPLC method by using 22 factorial design for designing the experiments for selected independent factors. Method Operable Design Region was developed for finding out the optimized chromatographic conditions. Further quality control parameters such as macroscopic and microscopic characters, physicochemical and phytochemical characterization including determination of toxic elements were carried out on the herb. Results: By application of QbD approach the optimized mobile phase was identified as water with 0.01% Hydrochloric acid and Methanol in the ratio of 70:30, with the flow rate of 1 mL/ min and UV detection at 263 nm. The linear model was established in the range of 2-10μg/mL with R2 value 0.998. The retention time of Trigonelline was found to be 2.877 min and the amount of Trigonelline in T. foenum-graecum L. Seeds was found to be 0.58%. The inter-day and intra-day precision were less than 2%, with accuracies between 96.6-110% of the true values. The quality control parameters showed the results within specified limits and the seeds showed absence of toxic elements in it. Conclusion: From the above finding we can conclude that the application of QbD approach for standardization of herbal drug can serve as an important tool for development of herbal drugs with desired quality.
Keywords
Subject
Article metadata
| Title | Standardization of Trigonella foenum-graecum L. Seeds: A Quality by Design Approach |
|---|---|
| Authors | Vishakha Parab Gaonkar; Kirankumar Hullatti; Vinodh Mannur |
| Affiliations | Department of Pharmacognosy, KLE College of Pharmacy, Belagavi, KLE Academy of Higher Education and Research (KAHER) Belagavi, Karnataka, INDIA.; Department of Pharmaceutical Quality Assurance, KLE College of Pharmacy, Belagavi, KLE Academy of Higher Education and Research (KAHER) Belagavi, Karnataka, INDIA. |
| Corresponding author | kkhullatti@gmail.com |
| Journal | Indian Journal of Pharmaceutical Education and Research |
| Volume / Issue | Vol. 54, Issue 4 (2020) |
Also in this issue
- Reduced Pharma Supply Chain in COVID-19: Measures to Reduce India’s Reliance for Active Pharmaceutical Ingredients on China and other Countriespp. 835–842
- Artificial Intelligence: A New Paradigm for Pharmaceutical Applications in Formulations Developmentpp. 843–846
- An Outbreak of Severe Acute Respiratory Syndrome-2019 (COVID-19): A Major Health Concernpp. 847–857
- Pharmaceutical and Biotechnological Importance of Actinobacterial Productspp. 858–864
- Using Chloroquine and Hydroxychloroquine in the Treatment of COVID-19: Does It Make Sense?pp. 865–874